HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Industry Must Be More Proactive Vs. NGOs In Shaping Cosmetics Regulation

This article was originally published in The Rose Sheet

Executive Summary

With non-governmental organizations calling for tighter personal-care regulation and commanding increasing attention on Capitol Hill, industry needs to take assertive measures to ensure it is not left out of the conversation, according to Wylie Royce, senior vice president of Royce Associates, an East Rutherford, N.J.-based dyes and specialty chemicals firm

You may also be interested in...



Industry Council, Safe Cosmetics Group To Push Separate Legislation In 2011

With consensus that the game-changing Safe Cosmetics Act of 2010 will not move forward this year, industry stakeholders are readying for the next legislative session

Council Celebrating Industry's Contribution To Economy At 2010 Meeting

The Personal Care Products Council will continue to focus on cosmetics legislation in 2010 while promoting the industry's positive impact on the U.S. economy and working to help members stay competitive in a trying market

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017244

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel